Furmaniak J, Sanders J, Sanders P, Miller-Gallacher J, Ryder M M, Rees Smith B
FIRS Laboratories, RSR Ltd, Cardiff, UK.
Mayo Clinic, Rochester, NY, USA.
Endocrine. 2020 May;68(2):261-264. doi: 10.1007/s12020-019-02180-9. Epub 2020 May 29.
Studies on the TSH receptor (TSHR) have numerous practical applications in vitro and in vivo. For example human monoclonal autoantibodies (MAbs) to the TSHR are useful reagents for in vitro diagnostics. Measurement of TSHR autoantibodies (TRAbs) is helpful in diagnosis and management of autoimmune thyroid disease. Currently available highly sensitive and specific assays to measure TRAbs use the human TSHR MAb M22 instead of the TSH. Furthermore, preparations of the human TSHR MAb M22 are useful as the World Health Organisation International Standard for thyroid stimulating antibody and for calibration of the assays for measuring TRAbs. Preparations of thermostabilised TSHR extracellular domain have recently become available and this is likely to have an impact on improvements in specificity testing for TRAb assays. In addition the stable TSHR preparations have practical application for specific immunoadsorption of patient serum TRAbs. Human TSHR MAbs also have promising prospects as new therapeutics. Autoantibodies with TSHR antagonistic activities are "natural" inhibitors of TSHR stimulation and are expected to be helpful in controlling TSHR activity in patients with Graves' disease, Graves' ophthalmopathy and thyroid cancer.
对促甲状腺激素受体(TSHR)的研究在体外和体内有众多实际应用。例如,针对TSHR的人单克隆自身抗体(MAb)是体外诊断的有用试剂。促甲状腺激素受体自身抗体(TRAb)的检测有助于自身免疫性甲状腺疾病的诊断和管理。目前可用于测量TRAb的高灵敏度和特异性检测方法使用人TSHR单克隆抗体M22而非促甲状腺激素(TSH)。此外,人TSHR单克隆抗体M22制剂可用作世界卫生组织甲状腺刺激抗体国际标准品以及用于校准测量TRAb的检测方法。热稳定的TSHR细胞外结构域制剂最近已可获得,这可能会对改进TRAb检测的特异性测试产生影响。此外,稳定的TSHR制剂在患者血清TRAb的特异性免疫吸附方面有实际应用。人TSHR单克隆抗体作为新的治疗药物也有广阔前景。具有TSHR拮抗活性的自身抗体是TSHR刺激的“天然”抑制剂,有望有助于控制格雷夫斯病、格雷夫斯眼病和甲状腺癌患者的TSHR活性。